Viatris recalls Lyrica CR (pregabalin) extended release tablets, 330 mg, 30-
See all recalls from Viatris →Recalled Product
Lyrica CR (pregabalin) extended release tablets, 330 mg, 30-count bottles, Rx only, Distributed by Parke-Davis Division of Pfizer Inc., NY, NY 10017, NDC 0071-1029-01
Hazard / Issue
Failed Dissolution Specifications
Issued by
FDA
Distribution: Nationwide (United States)
Lot/Code Info: Lot #: DN5396, EP9726, EK2417, Exp. Date August 2022
✅ What Should You Do?
- 1Stop taking this medication and contact your doctor or pharmacist immediately.
- 2Do NOT flush medications down the drain — use an FDA-approved drug take-back program.
- 3Check the lot number on your bottle or packaging against the recalled lots listed above.
- 4Report adverse events to FDA MedWatch or call 1-800-FDA-1088.
Looking for a safe alternative?
Search Amazon for Lyrica CR (pregabalin) extended →If you were harmed by this recalled product, Top Class Actions lists active class action lawsuits and settlements that may apply to you.
Get the next US recall alert before it hits the news.
Free. Weekly digest or instant alerts. Unsubscribe anytime.
CAN-SPAM compliant · No spam · Unsubscribe anytime